Eric D. Austin, MD, MSCI

Eric D. Austin, MD, MSCI

Associate Professor of Pediatrics
Allergy/Immunology/Pulmonary Medicine
Director, Vanderbilt Pediatric Pulmonary Hypertension Program
Allergy/Immunology/Pulmonary Medicine
Delivery Address
Doctors' Office Tower
2200 Children's Way
Room / Suite
Clinic Phone
(615) 343-7617

Pulmonary Medicine, Pediatric
Emory University School of Medicine, 2001
Vanderbilt University School of Medicine, Nashville, TN, 2008
Chief Residency-University of Colorado Health Sciences Center
Pediatric Residency-University of Colorado Health Sciences Center
Pediatric Pulmonary Fellowship-Vanderbilt University Medical Center

Clinical Interests

Pulmonary hypertension, pulmonary vascular disease, developmental lung diseases

Research Information

Dr. Austin is a pediatric pulmonary medicine and pulmonary hypertension (PH) specialist, physician scientist and an Associate Professor of Pediatrics at Vanderbilt University Medical Center.

Under his leadership, the Pediatric PH Program is a Pediatric Pulmonary Hypertension Network (PPHNet) Center as well as an accredited pediatric center of excellence in the national Pulmonary Hypertension Care Centers (PHCC) Program.

His research focuses upon inherent and extrinsic features of risk of, and resilience to, pulmonary hypertension in children and adults. With collaborators, he explores risk and resilience with clinical trial and observational research studies, incorporating genetic, genomic, and other biochemical features. Current NIH-funded projects include a clinical trial of sex hormone modification in adults with pulmonary arterial hypertension (PAH), a clinical trial of behavior modification of exercise in adolescents with PAH, an observational cohort study of individuals at risk of heritable PAH, and a collaborative observational cohort study of cardiopulmonary defects among formerly preterm children.

Dr. Austin is President-elect of the Society for Pediatric Research and is also President & Chair of the Scientific Leadership Council of the nonprofit foundation, TBX4Life, which promotes international science, clinical care, and advocacy for individuals impacted by genetic risk of pulmonary hypertension and other features of TBX4 Syndrome.

With a passion for training and education in patient-oriented research, Dr. Austin has directed the Vanderbilt Master of Science in Clinical Investigation (MSCI) Program since 2017.

>> View Publications on PubMed